FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of pharmaceutics and medicine and deals with anticancer pharmaceutical composition or combination for prevention cancer of lungs or cancer of kidney, which contains as active ingredients medication, which is produced from gefitinib, erlotinib and soraphenib, and dihydrochloride 5-(4-(6-(4-amino-3,5-dimetylphenoxy)-1-metyl-1H-benzimidazol-2-ilmethoxy)benzyl)thiazolidine-2,4-dione.
EFFECT: invention insures increased efficiency of treatment.
16 cl, 5 dwg, 3 tbl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
| NEW COMPOUND AND PHARMACEUTICAL COMPOSITION FOR INCREASING ANTICANCER ACTIVITY, CONTAINING SAID COMPOUND | 2019 |
|
RU2781282C1 |
| PPAR-SUPPORTING THIAZOLIDINEDIONES AND THEIR COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2010 |
|
RU2570424C2 |
| ANTIDIABETIC OXAZOLIDINEDIONES | 2005 |
|
RU2355682C2 |
| AGENTS FOR TREATMENT AND PROPHYLAXIS OF NEOPLASMS | 2000 |
|
RU2219928C2 |
| NEW METHOD FOR SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2593370C2 |
| FUNCTIONALISED DERIVATIVES OF MORPHOLINYLANTHRACYCLINE | 2015 |
|
RU2715902C2 |
| THIOPHENE DERIVATIVE AND ITS USE | 2019 |
|
RU2781643C2 |
| NEW PIPERIDINE COMPOUND OR SALT THEREOF | 2013 |
|
RU2581834C1 |
| SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2594725C2 |
